// App-Quantinova.ai

P161 : Faecal calprotectin identifies microscopic inflammation in ulcerative colitis patients with complete endoscopic healing: a post-hoc analysis of the MOMENTUM trial

Researchers

Presenter

  • T W Stevens

Principal Investigators

  • K Gecse

  • K Barrett

  • J R Turner

  • G de Hertogh

  • D T Rubin

  • G R DHaens

Medical Centers

  • Shire, Basingstoke, UK

  • Brigham and Women's Hospital and Harvard Medical School, Department of Pathology, Boston, USA

  • KU Leuven, Leuven, Belgium

  • University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago, IL, USA

Locations

  • Netherlands

  • United Kingdom

  • United States

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ulcerative colitis

Biomarkers

  • Faecal calprotectin

Drug/Treatment

  • Mesalamine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • IV

Study Id's

  • NCT01124149

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved